Sanofi

Sanofi is a global healthcare leader that researches, develops, manufactures, and markets therapeutic solutions across the United States, Europe, and internationally.

The company operates through three main segments:

• Pharmaceuticals: This segment offers specialty care products, including human monoclonal antibodies; treatments for multiple sclerosis, neurology, inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; diabetes medicines; cardiovascular and established prescription products.

• Vaccines: Sanofi provides a range of vaccines, including those for poliomyelitis, pertussis, and Hib for pediatric use; influenza, adult boosters, meningitis, and vaccines for travel and endemic diseases.

• Consumer Healthcare: Products in this segment include treatments for allergies, cough and cold, pain, liver care, and digestive health, alongside nutritional products and skin care items like daily body lotions and creams for specific conditions like eczema.

Sanofi collaborates on significant projects, including a joint effort with GlaxoSmithKline to develop a Covid-19 vaccine and a research partnership with Stanford University School of Medicine focusing on immunology and inflammation. Additionally, it has an agreement with Prellis Biologics, Inc., to expand its biotechnology endeavors.

Founded in 1973 and formerly known as Sanofi-Aventis, the company changed its name to Sanofi in 2011.

Its headquarters are located in Paris, France.